Metropolitan Life Insurance Company (MetLife)’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-30,577
Closed -$116K 2631
2020
Q1
$116K Buy
30,577
+874
+3% +$3.32K ﹤0.01% 1941
2019
Q4
$151K Buy
29,703
+9,429
+47% +$48K ﹤0.01% 2095
2019
Q3
$102K Sell
20,274
-4,938
-20% -$25K ﹤0.01% 2290
2019
Q2
$156K Buy
25,212
+4,460
+21% +$27.5K ﹤0.01% 2056
2019
Q1
$96.3K Sell
20,752
-6,769
-25% -$31.4K ﹤0.01% 2345
2018
Q4
$116K Buy
27,521
+3,538
+15% +$14.9K ﹤0.01% 2174
2018
Q3
$150K Hold
23,983
﹤0.01% 2199
2018
Q2
$193K Hold
23,983
﹤0.01% 1966
2018
Q1
$179K Buy
23,983
+7,075
+42% +$52.8K ﹤0.01% 1957
2017
Q4
$101K Buy
+16,908
New +$101K ﹤0.01% 2307
2017
Q3
Sell
-48,263
Closed -$328K 2560
2017
Q2
$328K Hold
48,263
﹤0.01% 2000
2017
Q1
$456K Buy
48,263
+2,291
+5% +$21.6K ﹤0.01% 1708
2016
Q4
$397K Sell
45,972
-3,102
-6% -$26.8K ﹤0.01% 1881
2016
Q3
$311K Sell
49,074
-1,113
-2% -$7.05K ﹤0.01% 2044
2016
Q2
$212K Hold
50,187
﹤0.01% 2286
2016
Q1
$219K Hold
50,187
﹤0.01% 2117
2015
Q4
$308K Buy
50,187
+4,820
+11% +$29.6K ﹤0.01% 1945
2015
Q3
$259K Sell
45,367
-3,837
-8% -$21.9K ﹤0.01% 2101
2015
Q2
$367K Buy
+49,204
New +$367K ﹤0.01% 1966
2015
Q1
Sell
-53,538
Closed -$405K 2528
2014
Q4
$405K Hold
53,538
﹤0.01% 1917
2014
Q3
$278K Sell
53,538
-17,190
-24% -$89.3K ﹤0.01% 2137
2014
Q2
$305K Hold
70,728
﹤0.01% 2192
2014
Q1
$289K Buy
70,728
+6,309
+10% +$25.8K ﹤0.01% 2208
2013
Q4
$343K Buy
64,419
+23,250
+56% +$124K ﹤0.01% 2083
2013
Q3
$207K Hold
41,169
﹤0.01% 2400
2013
Q2
$184K Buy
+41,169
New +$184K ﹤0.01% 2405